Showing results (1-10 of 289) with videos related to

Sort By:
Pageof 29
The Journal of Infectious Diseases|May 1, 1995
New virologic tools for the design and analysis of clinical trialsR W Shafer, T C Merigan
Antimicrobial Agents and Chemotherapy|August 3, 1999
Hydroxyurea enhances the activities of didanosine, 9-[2-(phosphonylmethoxy)ethyl]adenine, and 9-[2-(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolatesS Palmer, R W Shafer, T C Merigan
AIDS (London, England)|July 9, 1999
Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical developmentS Palmer, R W Shafer, T C Merigan
Journal of Clinical Microbiology|January 1, 1995
Quantitative analysis of syncytium-inducing and non-syncytium-inducing virus in patients infected with human immunodeficiency virus type 1R W Shafer, E Aguiniga, T C Merigan
The Journal of Infectious Diseases|March 1, 1997
A novel approach to assessing the drug susceptibility and replication of human immunodeficiency virus type 1 isolatesR M Jellinger, R W Shafer, T C Merigan
Annals of Internal Medicine|June 20, 1998
Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patientsR W Shafer, M A Winters, S Palmer, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
Genotypic and phenotypic changes during culture of a multinucleoside-resistant human immunodeficiency virus type 1 strain in the presence and absence of additional reverse transcriptase inhibitorsR W Shafer, M A Winters, A K Iversen, et al.
Journal of Virology|July 1, 1997
Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in ZimbabweR W Shafer, J A Eisen, T C Merigan, et al.
The Journal of Infectious Diseases|March 1, 1993
A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipientsM J Kozal, R W Shafer, M A Winters, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1997
Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 yearsM A Winters, R W Shafer, R A Jellinger, et al.
Pageof 29